Galectin Therapeutics Inc (NAS:GALT)
$ 3.45 +0.23 (+7.14%) Market Cap: 347.93 Mil Enterprise Value: 471.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 22/100

Galectin Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 03, 2025 / 04:00PM GMT
Release Date Price: $5.7 (+4.40%)
Kevin D. Freeman Galectin Therapeutics Inc;Independent Director

Good morning, ladies and gentlemen. Welcome. My name is Kevin Freeman and I'm the Vice Chairman of the Board of Galectin Therapeutics Inc. I will act as Chair of this meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as Secretary.

Due to cost savings and other efficiencies, we're holding this year's Annual Meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.

I hereby call the 2025 Annual Meeting for Galectin Therapeutics Inc. To order. At this time, I would like to introduce the current members of the Board of Directors. We have Dr. Gilbert Amelio, Director, Member of the Compensation Committee and Chair of the Nominating and Corporate Governance Committee; Dr. Benjamin S. Carson, Senior Director; Mr. Kary Eldred, Director and Member of the Audit Committee.

I am the Director, a member of the Audit Committee, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot